CA3105328A1 - Method for producing diarylpyridine derivatives - Google Patents
Method for producing diarylpyridine derivatives Download PDFInfo
- Publication number
- CA3105328A1 CA3105328A1 CA3105328A CA3105328A CA3105328A1 CA 3105328 A1 CA3105328 A1 CA 3105328A1 CA 3105328 A CA3105328 A CA 3105328A CA 3105328 A CA3105328 A CA 3105328A CA 3105328 A1 CA3105328 A1 CA 3105328A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- added
- contents
- compound represented
- stirred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-127197 | 2018-07-04 | ||
| JP2018127197 | 2018-07-04 | ||
| PCT/JP2019/026395 WO2020009132A1 (ja) | 2018-07-04 | 2019-07-03 | ジアリールピリジン誘導体の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3105328A1 true CA3105328A1 (en) | 2020-01-09 |
Family
ID=69059540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3105328A Pending CA3105328A1 (en) | 2018-07-04 | 2019-07-03 | Method for producing diarylpyridine derivatives |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11999724B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3819296B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7337058B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112368271A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019299152A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3105328A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2925365T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL279070B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI840378B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020009132A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2023090337A1 (cg-RX-API-DMAC7.html) | 2021-11-19 | 2023-05-25 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201404505PA (en) * | 2012-01-31 | 2014-10-30 | Daiichi Sankyo Co Ltd | Pyridone derivative |
| TWI723572B (zh) * | 2014-07-07 | 2021-04-01 | 日商第一三共股份有限公司 | 具有四氫吡喃基甲基之吡啶酮衍生物及其用途 |
| TWI796326B (zh) | 2017-03-24 | 2023-03-21 | 日商第一三共股份有限公司 | 含有ａｘｌ抑制劑與ｅｇｆｒ酪胺酸激酶抑制藥的醫藥品及其用途 |
-
2019
- 2019-07-01 TW TW108123125A patent/TWI840378B/zh not_active IP Right Cessation
- 2019-07-03 JP JP2020529019A patent/JP7337058B2/ja active Active
- 2019-07-03 WO PCT/JP2019/026395 patent/WO2020009132A1/ja not_active Ceased
- 2019-07-03 AU AU2019299152A patent/AU2019299152A1/en not_active Abandoned
- 2019-07-03 EP EP19831009.6A patent/EP3819296B1/en active Active
- 2019-07-03 US US17/252,469 patent/US11999724B2/en active Active
- 2019-07-03 CA CA3105328A patent/CA3105328A1/en active Pending
- 2019-07-03 ES ES19831009T patent/ES2925365T3/es active Active
- 2019-07-03 CN CN201980043226.0A patent/CN112368271A/zh active Pending
- 2019-07-03 IL IL279070A patent/IL279070B2/en unknown
-
2023
- 2023-08-22 JP JP2023134392A patent/JP2023159297A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202005962A (zh) | 2020-02-01 |
| US20210188823A1 (en) | 2021-06-24 |
| JP2023159297A (ja) | 2023-10-31 |
| ES2925365T3 (es) | 2022-10-17 |
| IL279070B2 (en) | 2024-05-01 |
| JPWO2020009132A1 (ja) | 2021-07-08 |
| CN112368271A (zh) | 2021-02-12 |
| WO2020009132A1 (ja) | 2020-01-09 |
| EP3819296B1 (en) | 2022-06-29 |
| AU2019299152A1 (en) | 2021-03-04 |
| US11999724B2 (en) | 2024-06-04 |
| AU2019299152A2 (en) | 2021-03-11 |
| IL279070A (en) | 2021-01-31 |
| TWI840378B (zh) | 2024-05-01 |
| IL279070B1 (en) | 2024-01-01 |
| EP3819296A4 (en) | 2021-06-09 |
| EP3819296A1 (en) | 2021-05-12 |
| JP7337058B2 (ja) | 2023-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11629153B2 (en) | Forms and compositions of a MK2 inhibitor | |
| US20070203178A1 (en) | Crystalline solvates of apixaban | |
| CA2757458A1 (en) | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | |
| AU2023201059A1 (en) | Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione | |
| BR112013023480B1 (pt) | Composto heterocíclico saturado contendo nitrogênio, seu uso e composição farmacêutica | |
| KR102183356B1 (ko) | Fgfr 억제제를 제조하기 위한 방법 | |
| EP3819296B1 (en) | Method for producing diarylpyridine derivatives | |
| JP2017114875A (ja) | アルキニルケトン誘導体の製造方法 | |
| KR102891811B1 (ko) | 3-(5-플루오로벤조푸란-3-일)-4-(5-메틸-5H-[1,3]디옥솔로[4,5-f]인돌-7-일)피롤-2,5-디온의 고체 형태 | |
| WO2016172333A1 (en) | A solid state form of perampanel | |
| BRPI0708560A2 (pt) | processo para a preparação de um composto, e, composto | |
| Ma et al. | Microwave-assisted Synthesis of New 1, 3-thiazolidin-4-ones and Evaluation of Their Anticancer Efficacy | |
| JP2020535192A (ja) | レナリドミドの結晶形 | |
| CN120957997A (zh) | 一种含氮四环化合物的结晶形式及其制备方法 | |
| KR20240089380A (ko) | 마보릭사포의 합성 및 그 중간체 | |
| CN106317045B (zh) | 一种氟罗沙星(绕丹宁不饱和酮)酰胺类衍生物及其制备方法和应用 | |
| HK40047091A (en) | Method for producing diarylpyridine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220923 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20240807 |